Skip to main content

Together we are beating cancer

Donate now

ASCO conference

Showing 12 out of 33 results

From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference. From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference.

by Nick Peel | Analysis | 15 June 2016

15 June 2016

ASCO 2015
  • Science & Technology
  • Health & Medicine

ASCO 2015 round-up: immunotherapy continues to come of age

We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference. We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference.

by Alan Worsley | Analysis | 5 June 2015

5 June 2015

vitamin pills

This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story

by Henry Scowcroft | Analysis | 15 May 2015

15 May 2015

A handshake
  • Science & Technology
  • Health & Medicine

New immunotherapy drugs hit the headlines - how do they work?

In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers. In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers.

by Henry Scowcroft | Analysis | 2 June 2014

2 June 2014